FDA applicant
Accelerate Diagnostics, Inc.
FDA records 2 decisions for Accelerate Diagnostics, Inc. (Tucson, AZ) from 2020 to 2024: 2 510(k) clearances. Most are in product codes PRH (Positive Blood Culture Identification And Ast…) and QNJ (Mass Spectrometry, Microorganism…). Its devices cite 2 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Accelerate Diagnostics, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
2in 2022
Class I Class II/III not classified
Planning a device like Accelerate Diagnostics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Accelerate”
FDA records each applicant name separately; these may or may not be the same firm.